Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?
Main Authors: | Georgios Christopoulos, Panithaya Chareonthaitawee |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-08-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-017-0322-z |
Similar Items
-
Diagnosis of isolated cardiac sarcoidosis based on new guidelines
by: Hideki Kawai, et al.
Published: (2020-10-01) -
Mucinous urachal adenocarcinoma: A potential nonfluorodeoxyglucose-avid pitfall on 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography
by: Jeeban Paul Das, et al.
Published: (2020-01-01) -
Prevalence of cancer and the benign call rate of afirma gene classifier in 18F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules
by: Mayumi Endo, et al.
Published: (2021-02-01) -
The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma
by: Athanasios Bantis, et al.
Published: (2016-01-01) -
Presentation of unusual tracheal metastasis on Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography after 9 years in postnephrectomy patient of renal cell carcinoma: A case report and review of literature
by: Rahul Vithalrao Parghane, et al.
Published: (2017-01-01)